Pharma
Stay updated with the latest happenings in the pharmaceutical industry. Get insights into drug development, innovations, regulatory updates, and emerging trends. Discover the advancements shaping the future of healthcare. Explore the world of pharma with our comprehensive coverage at Pharmtales.com.
Sarepta Therapeutics Sells Rare Pediatric Disease Priority Review Voucher for $102 Million to Boost Research and Development
Source – Sarepta Therapeutics On July 5, 2023, Sarepta Therapeutics, a leading company in precision genetic medicine for rare diseases, ...
European Commission Grants Approval for ORKAMBI to Treat Cystic Fibrosis in Children Aged 1 to <2 Years
Source – Vertex Pharmaceuticals On July 5, 2023, Vertex Pharmaceuticals announced that the European Commission has granted approval for the ...
Novartis to Appeal Court Decision on Entresto Combination Patent; Confirms 2023 Guidance and Mid-Term Outlook
Source: Novartis On July 7, 2023, Novartis received a negative decision from the US District Court regarding the validity of ...
Long-Term Results from MIRROR Trial: KRYSTEXXA Injection Combined with Methotrexate Reveals Promising Outcomes
Source – Horizon On July 6, 2023, Horizon Therapeutics announced the publication of long-term data from the MIRROR randomized controlled ...
LifeArc’s project for rare diseases will spend £100 million on patient care
Source – LifeArc LifeArc, a self-funded non-profit medical research organization and charity, has announced the launch of the Rare Disease ...
New Study Demonstrates Psilocybin as Affordable and Effective Treatment for Major Depression
Research conducted by Clerkenwell Health and the University of Greenwich suggests that psilocybin, a psychedelic compound found in certain mushrooms, ...
FDA approves Astellas’ zolbetuximab BLA for priority review
Source – Astellas Pharma On July 6 2023, Astellas Pharma announced that the US Food and Drug Administration (FDA) has ...
Enterovirus – Echovirus 11 Infection: A New Emerging Disease in Europe That You Need to Know About
Enteroviruses are a group of viruses that can cause various diseases in humans, ranging from mild respiratory infections to severe ...
FDA Grants Approval to Epcoritamab– Redefining the Future of DLBCL
In the world of cancer treatment, groundbreaking advancements are constantly being made, offering new hope for patients and their loved ...
Bernie Sanders suggests placing price limitations on medications created with public funding
Following his appointment as chairman of the Senate Health, Education, Labor, and Pensions Committee, Senator Bernie Sanders from Vermont, a ...
Eisai and Biogen Embark on Full Launch of Leqembi Following Alzheimer’s Approval
Source – Eisai On July 6, 2023, Eisai and Biogen received full approval from the FDA for their Alzheimer’s disease ...
Pirtobrutinib Shows Promise as a Novel CLL/SLL Treatment for Patients Previously Treated with BTK Inhibitors
Source – Eli Lilly On July 6, 2023, Eli Lilly and Company’s oncology unit announced that The New England Journal ...
Moderna Submits Global Regulatory Applications for its RSV Vaccine, mRNA-1345
Source – Moderna On July 5, 2023 Moderna, a biotech company at the forefront of mRNA vaccines, shared an update ...
Respiratory Syncytial Virus Infection: The Latest Research
If you have a young child or an elderly relative, you may have heard of respiratory syncytial virus (RSV). It’s ...
Relapsed/Refractory Marginal Zone Lymphoma Reacts to Abivertinib
A Phase IIa trial conducted in China demonstrated that treatment with the irreversible BTK inhibitor abivertinib (Fujovee) resulted in responses ...
Positive new Phase III MRI results from the NMOSD study UPLIZNA
Source – Horizon Therapeutics Horizon Therapeutics unveiled positive MRI data from a Phase III clinical trial of UPLIZNA (inebilizumab) at ...
Moderna to research and manufacture mRNA meds in China under $1B agreement
Despite ongoing political tensions between the United States and China, foreign investments in the pharmaceutical sector are progressing in China. ...
FDA rejects Amneal’s Parkinson’s drug, $500M peak sales goal unattainable
Source – Amneal Pharmaceuticals On July 3, 2023, Amneal Pharmaceuticals’ plans to launch its extended-release Parkinson’s disease treatment, IPX203, by ...
Sanofi teams up with local pharma firms for vaccine production in Saudi Arabia
Following recent developments by AstraZeneca and National Resilience in the United Arab Emirates, Sanofi has emerged as the next major ...
FDA Approves Cyclophosphamide Injection NDA for Multiple Cancers
Source – Nevakar Injectables On July 3, 2023 the FDA has approved a new drug application (NDA) for 200-mg/mL vials ...
Zenocutuzumab receives Breakthrough Designation from the FDA for NRG1+ Pancreatic Cancer
Source – Merus On July 5, The FDA has granted breakthrough therapy designation to zenocutuzumab (MCLA-128) as a treatment for ...
Ewing Sarcoma Pathology Outlines: Essential Insights You Should Know
Ewing sarcoma is a rare and aggressive type of cancer that affects the bones and soft tissues of children and ...
Comprehensive Guide to Kaposi Sarcoma Treatment
In this blog post, we will focus on the kaposi sarcoma treatment options, including chemotherapy, radiotherapy, surgery, immunotherapy, and antiretroviral ...
Unlocking Hope: Curious Advances in Ewing Sarcoma Cancer Treatment, Paving the Way to Brighter Futures
Ewing Sarcoma Cancer is a rare form of cancer that primarily affects the bones or the soft tissues surrounding them. ...
Janssen rejoices at JNJ-2113A’s successful psoriasis study findings
Source – Johnson & Johnson On July 4, 2023, Janssen, a subsidiary of Johnson & Johnson announced positive initial results ...
For its updated Covid-19 vaccine, Moderna submits a regulatory application to the European Medicines Agency
Source – Moderna On July 3, 2023 Moderna announced the submission of a regulatory application to the European Medicines Agency ...
Nivolumab and Ipilimumab Together Prolong Survival in Metastatic RCC
Kidney cancer, or renal cell carcinoma (RCC), is one of the most common types of cancer in adults, affecting about ...
How to Counsel Patients on Immunotherapy Discontinuation in RCC
Immunotherapy has revolutionized the treatment of metastatic renal cell carcinoma (RCC), a type of kidney cancer that is often resistant ...
Healthcare bucks the trend with a 2-year M&A high
On July 4, Data from LSEG Deals Intelligence revealed that the healthcare sector experienced a notable 35% increase in deals, ...
MDMA and psilocybin were originally prescribed for depression and PTSD in Australia
Australia made history on July 3rd by becoming the first country to allow psychiatrists to prescribe MDMA, commonly known as ...
